Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TYRO3 |
| Upstream (Parents) |
|---|
| (<<) ATXN1 → TYRO3 |
| (<<) GBP2 → TYRO3 |
| (<<) HDAC2 → TYRO3 |
| (<<) HMGA2 → TYRO3 |
| (<<) IL23A → TYRO3 |
| (<<) MAPKAPK5 → TYRO3 |
| (<<) PLK1 → TYRO3 |
| (<<) RECK → TYRO3 |
| (<<) SEMA3A → TYRO3 |
| (<<) SEPW1 → TYRO3 |
| (<<) TYK2 → TYRO3 |
| Downstream (Children) |
|---|
| TYRO3 → CAV3 (>>) |
| TYRO3 → DHCR7 (>>) |
| TYRO3 → GRK6 (>>) |
| TYRO3 → IL1R2 (>>) |
| TYRO3 → MAP3K5 (>>) |
| TYRO3 → MAPKAP1 (>>) |
